ALFA Finder
18:34 IST
NSE
Dividend
Concord Biotech Dividend
Concord Biotech recommended a final dividend of ₹7.55 per equity share for FY 2025-26. The record date for payment is July 24, 2026.
Concord Biotech Ltd
- Share price
- ₹597.20
- Market cap
- ₹12,495 Cr
- Revenue (annual)
- ₹1,055 Cr
- Net profit (annual)
- ₹260.9 Cr
- P/E (TTM)
- 44.2×Sector 43.8×
- Promoter holding
- 44.09%+0.01% QoQ
- FII holding
- 7.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 7Bonus Issue 5Other Announcement 4Financial Results 4Board Meeting Date 4Regulatory Approval 3Business Update 2Annual General Meeting 2Management Change 1Legal & Regulatory 1Dividend 1Annual Report 1
Time
35 announcements
18:19 IST
BSE
Financial Results
Concord Biotech Q4 FY26 Results: Net Profit ₹88.5 Cr, Down 37.0% YoY
Concord Biotech Ltd reported revenue from operations of ₹326.1 Cr (-24.1% YoY) and net profit of ₹88.5 Cr (-37.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹88.5 Cr · -37.0% YoY
18:18 IST
BSE
Financial Results
Concord Biotech Financial Results
Concord Biotech approved its FY26 audited financial results and recommended a final dividend of Rs. 7.55 per share. It also appointed Mrs. Ekta Gupta as an Additional Independent Director.
10:36 IST
BSE
Board Meeting Date
Concord Biotech Board Meeting Date
Concord Biotech scheduled a board meeting on May 29, 2026, to approve annual financial results. The board will also consider recommending a final dividend.
10:52 IST
BSE
Other Announcement
Concord Biotech Other Announcement
Concord Biotech Limited submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The Registrar and Share Transfer Agent, MUFG Intime India, confirmed that no dematerialization or rematerialization requests were received during this period.